Home > Resources > Whitepapers > Analysis of Pharmaceutical Raw Materials Through Packaging Using an FT-NIR Fiber Optic Probe

Analysis of Pharmaceutical Raw Materials Through Packaging Using an FT-NIR Fiber Optic Probe

November 28, 2018

The analysis of all incoming pharmaceutical raw materials is key part of 21CFR compliance. It is therefore important to have a high-throughput method by which raw materials may be analyzed, while also preventing sample exposure. This application note explores the analysis and identification of various commonplace pharmaceutical raw materials through both one and two layers of clear polyethylene bags using the PerkinElmer Spectrum Two N Remote Sampling Module and Spectrum Touch Software.

Spotlight

Universal Genetics

Universal Genetics is a leading DNA paternity and forensic testing center in the United States. We have three fully-operating laboratories conveniently located in Los Angeles, New York and Miami. Our staff includes some of the nation’s most reputable and experienced DNA scientists. All of our laboratories are accredited by American Associate of Blood Bank (AABB) and are listed on AABB as Advanced Immigration Genetics - Universal Genetics and Advanced Genetics. We are the only AABB-accredited DNA paternity testing laboratory directed by a Medical Doctor. Our state-of-art DNA testing facility has the most advanced equipment, certified clean rooms and the latest robotic technology. With Universal Genetics, you can expect professional and friendly service delivered by our DNA test experts. We provide multi-language services, including English, Spanish, Chinese, Vietnamese, Korean and Italian.

OTHER WHITEPAPERS

Nanoform Management Presentation

whitePaper | May 24, 2022

Our proprietary nanoforming technologies and services span the full range of drug development from small-molecule nanoparticles to large-molecule biologics.

Seize the digital momentum

whitePaper | January 23, 2023

Investments in biopharmaceutical (biopharma) research and development (R&D) continue to fuel innovation and shape the future of health. However, this year’s analysis demonstrates that despite impressive examples of innovative products the step-change in improved productivity seen in 2021 has not continued.

Manual No More: Automating the Scientific Data Lifecycle

whitePaper | May 23, 2022

The world’s scientific data today is a morass. 50-80% of research scientist and data scientist time is spent wrestling with data before they can focus on highervalue AI/ML and advanced analysis to help bring new life-saving therapeutics to market.

Multi-channel clinical trial recruitment technology checklist

whitePaper | August 8, 2022

Biopharma R&D professionals generally admit that the current "high-cost, high-risk" development model is unsustainable. Despite technological.

MOLECULAR GLUES LANDSCAPE IN DRUG DISCOVERY

whitePaper | June 21, 2022

nduced-proximity targeted protein degradation (TPD) is a ground-breaking strategy in drug discovery that has emerged during the last decade.

Manufacturing High-Quality Capsule Products for Pharmaceutical and Nutraceutical Applications

whitePaper | October 25, 2022

To confirm the suitability of empty hard capsules for use in the application of quality-by-design (QbD) in the development and manufacturing of finished pharmaceutical products, the quality target product profile (QTPP) defined by eight critical quality attributes (CQA’s) was examined.

Analysis of Pharmaceutical Raw Materials Through Packaging Using an FT-NIR Fiber Optic Probe